Rafferty Asset Management, LLC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 176 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Rafferty Asset Management, LLC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,450,439
-7.2%
220,097
-4.3%
0.01%
-27.3%
Q1 2023$1,562,284
+50.9%
230,086
+64.2%
0.01%
+22.2%
Q4 2022$1,035,635
-23.6%
140,140
+2.2%
0.01%
-35.7%
Q3 2022$1,355,000
+46.5%
137,166
+61.7%
0.01%
+55.6%
Q2 2022$925,000
-52.5%
84,845
-50.8%
0.01%
-25.0%
Q1 2022$1,949,000
-4.6%
172,322
+32.4%
0.01%
+9.1%
Q4 2021$2,043,000
+46.0%
130,197
+59.5%
0.01%
+10.0%
Q3 2021$1,399,000
-11.2%
81,639
+11.5%
0.01%0.0%
Q2 2021$1,575,000
+3.6%
73,211
-27.7%
0.01%0.0%
Q1 2021$1,520,000
+395.1%
101,201
+333.8%
0.01%
+233.3%
Q4 2020$307,000
-51.4%
23,330
-64.3%
0.00%
-62.5%
Q3 2020$632,000
+57.6%
65,394
+86.7%
0.01%
+33.3%
Q2 2020$401,000
-53.7%
35,021
-33.7%
0.01%
-53.8%
Q4 2019$867,000
-53.2%
52,858
-62.1%
0.01%
-55.2%
Q3 2019$1,852,000
-9.7%
139,456
-4.1%
0.03%
-19.4%
Q2 2019$2,050,000
-32.4%
145,484
-11.7%
0.04%
-26.5%
Q1 2019$3,033,000164,8520.05%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,525,476$74,263,0004.09%
ARMISTICE CAPITAL, LLC 2,828,000$46,407,0002.68%
Birchview Capital, LP 80,000$1,313,0000.95%
GLOBEFLEX CAPITAL L P 145,426$2,386,0000.45%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 231,733$3,803,0000.36%
361 CAPITAL LLC 77,630$1,274,0000.35%
CADENCE CAPITAL MANAGEMENT LLC 152,428$2,501,0000.27%
BOOTHBAY FUND MANAGEMENT, LLC 148,000$2,429,0000.21%
EMERALD ADVISERS, LLC 258,497$4,242,0000.18%
EMERALD MUTUAL FUND ADVISERS TRUST 251,730$4,131,0000.17%
View complete list of VANDA PHARMACEUTICALS INC shareholders